Terry Kind, MD, MPH: Building up the Academic Foundation for Pediatric Educators

July 30, 2020
Terry Kind

Terry Kind, MD, MPH, associate dean of clinical education and professor of pediatrics at the George Washington University School of Medicine and Health Sciences, was selected as a member of the Inaugural Cohort of the National Academy of Distinguished Educators in Pediatrics (NADEP). 

The newly created NADEP, which sits within the Academic Pediatric Association, will work to enhance the visibility and prestige of pediatric educators the United States and support the medical education community. 

Kind was chosen due to the depth and breadth of her educational experiences, expertise, and contributions to the field, according to the organization. She has held several national educational roles, and currently serves and an associate editor for Academic Pediatrics. 

Members of the inaugural cohort are charged with using their collective talent and energy to build a strong academic foundation for future educators by consultation and review, coaching and mentorship, and dissemination of cutting-edge ideas as visiting professors, as well as engaging in strategic thought leadership to impact the professional development of pediatric educators, according to the NADEP. 

Latest News

March 2, 2021
The George Washington University is participating in another COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a Phase II study for the Sanofi COVID-19 adjuvanted recombinant protein-based COVID-19 vaccine candidate.
February 25, 2021
The George Washington University (GW) Office of the Vice President for Research and the GW School of Medicine and Health Sciences gave COVID-19 research a shot in the arm through the FY21 COVID-19 Research Fund competition.
February 25, 2021
A group of interdisciplinary researchers at the George Washington University received more than $3.3 million in grants for their research on networks within the autonomic nervous system and therapies that may lead to new treatments for heart attack and sleep apnea.